vs

Side-by-side financial comparison of Everest Group (EG) and Emerson Electric (EMR). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $4.1B, roughly 1.1× Everest Group). Everest Group runs the higher net margin — 16.1% vs 13.9%, a 2.1% gap on every dollar of revenue. On growth, Emerson Electric posted the faster year-over-year revenue change (4.1% vs -4.6%). Over the past eight quarters, Emerson Electric's revenue compounded faster (-0.3% CAGR vs -1.9%).

Everest Group is a leading global reinsurance and insurance provider operating across over 100 countries. It offers diversified property, casualty, specialty, and life insurance products for commercial enterprises and individual customers, with strong risk management capabilities and long-standing industry expertise.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

EG vs EMR — Head-to-Head

Bigger by revenue
EMR
EMR
1.1× larger
EMR
$4.3B
$4.1B
EG
Growing faster (revenue YoY)
EMR
EMR
+8.7% gap
EMR
4.1%
-4.6%
EG
Higher net margin
EG
EG
2.1% more per $
EG
16.1%
13.9%
EMR
Faster 2-yr revenue CAGR
EMR
EMR
Annualised
EMR
-0.3%
-1.9%
EG

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
EG
EG
EMR
EMR
Revenue
$4.1B
$4.3B
Net Profit
$653.0M
$605.0M
Gross Margin
53.2%
Operating Margin
17.8%
Net Margin
16.1%
13.9%
Revenue YoY
-4.6%
4.1%
Net Profit YoY
211.0%
3.4%
EPS (diluted)
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EG
EG
EMR
EMR
Q1 26
$4.1B
Q4 25
$4.4B
$4.3B
Q3 25
$4.3B
$4.9B
Q2 25
$4.5B
$4.6B
Q1 25
$4.3B
$4.4B
Q4 24
$4.6B
$4.2B
Q3 24
$4.3B
$4.6B
Q2 24
$4.2B
$4.4B
Net Profit
EG
EG
EMR
EMR
Q1 26
$653.0M
Q4 25
$446.0M
$605.0M
Q3 25
$255.0M
$637.0M
Q2 25
$680.0M
$586.0M
Q1 25
$210.0M
$485.0M
Q4 24
$-593.0M
$585.0M
Q3 24
$509.0M
$996.0M
Q2 24
$724.0M
$329.0M
Gross Margin
EG
EG
EMR
EMR
Q1 26
Q4 25
53.2%
Q3 25
51.9%
Q2 25
52.6%
Q1 25
53.5%
Q4 24
53.5%
Q3 24
51.3%
Q2 24
52.8%
Operating Margin
EG
EG
EMR
EMR
Q1 26
Q4 25
12.5%
17.8%
Q3 25
6.2%
16.4%
Q2 25
18.1%
16.1%
Q1 25
5.8%
14.2%
Q4 24
-16.1%
18.6%
Q3 24
13.5%
14.7%
Q2 24
19.7%
10.4%
Net Margin
EG
EG
EMR
EMR
Q1 26
16.1%
Q4 25
10.1%
13.9%
Q3 25
5.9%
13.1%
Q2 25
15.1%
12.9%
Q1 25
4.9%
10.9%
Q4 24
-12.8%
14.0%
Q3 24
11.9%
21.6%
Q2 24
17.1%
7.5%
EPS (diluted)
EG
EG
EMR
EMR
Q1 26
Q4 25
$10.71
$1.07
Q3 25
$6.09
$1.12
Q2 25
$16.10
$1.04
Q1 25
$4.90
$0.86
Q4 24
$-13.59
$1.02
Q3 24
$11.80
$1.74
Q2 24
$16.70
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EG
EG
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$2.2B
Total DebtLower is stronger
$7.6B
Stockholders' EquityBook value
$15.3B
$20.3B
Total Assets
$62.3B
$41.9B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EG
EG
EMR
EMR
Q1 26
$2.2B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$662.0M
Q3 24
Q2 24
Total Debt
EG
EG
EMR
EMR
Q1 26
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Stockholders' Equity
EG
EG
EMR
EMR
Q1 26
$15.3B
Q4 25
$15.5B
$20.3B
Q3 25
$15.4B
$20.3B
Q2 25
$15.0B
$19.9B
Q1 25
$14.1B
$19.2B
Q4 24
$13.9B
$20.5B
Q3 24
$15.3B
$21.6B
Q2 24
$14.2B
$20.8B
Total Assets
EG
EG
EMR
EMR
Q1 26
$62.3B
Q4 25
$62.5B
$41.9B
Q3 25
$62.2B
$42.0B
Q2 25
$60.5B
$42.5B
Q1 25
$58.1B
$42.0B
Q4 24
$56.3B
$42.6B
Q3 24
$55.9B
$44.2B
Q2 24
$52.6B
$45.6B
Debt / Equity
EG
EG
EMR
EMR
Q1 26
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EG
EG
EMR
EMR
Operating Cash FlowLast quarter
$699.0M
Free Cash FlowOCF − Capex
$602.0M
FCF MarginFCF / Revenue
13.9%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
1.16×
TTM Free Cash FlowTrailing 4 quarters
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EG
EG
EMR
EMR
Q1 26
Q4 25
$-398.0M
$699.0M
Q3 25
$1.5B
$3.1B
Q2 25
$1.1B
$1.1B
Q1 25
$928.0M
$241.0M
Q4 24
$780.0M
$777.0M
Q3 24
$1.7B
$3.3B
Q2 24
$1.3B
$1.1B
Free Cash Flow
EG
EG
EMR
EMR
Q1 26
Q4 25
$602.0M
Q3 25
$2.7B
Q2 25
$977.0M
Q1 25
$154.0M
Q4 24
$694.0M
Q3 24
$2.9B
Q2 24
$998.0M
FCF Margin
EG
EG
EMR
EMR
Q1 26
Q4 25
13.9%
Q3 25
54.9%
Q2 25
21.5%
Q1 25
3.5%
Q4 24
16.6%
Q3 24
63.1%
Q2 24
22.8%
Capex Intensity
EG
EG
EMR
EMR
Q1 26
Q4 25
2.2%
Q3 25
8.9%
Q2 25
2.0%
Q1 25
2.0%
Q4 24
2.0%
Q3 24
9.1%
Q2 24
2.1%
Cash Conversion
EG
EG
EMR
EMR
Q1 26
Q4 25
-0.89×
1.16×
Q3 25
5.72×
4.86×
Q2 25
1.59×
1.83×
Q1 25
4.42×
0.50×
Q4 24
1.33×
Q3 24
3.41×
3.35×
Q2 24
1.85×
3.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EG
EG

Premiums earned$3.6B88%
Other$494.0M12%

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons